$ARIA Recent Headlines

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2014 at 10:35 AM

$ARIA Recent Headlines

Six stocks to watch
4:27 p.m. Feb. 26, 2014
- The Trading Deck

6 stocks to watch
4:34 p.m. Feb. 12, 2014
- The Trading Deck

Ariad falls after wild ride upward, while Care.com holds on to its gains

10:02 p.m. Jan. 27, 2014
- Russ Britt

Apple green ahead of earnings; Caterpillar tops gainers
4:42 p.m. Jan. 27, 2014
- Sue Chang

Ariad shares jump nearly 30% on rumors of Big Pharma takeover

2:43 p.m. Jan. 24, 2014
- Russ Britt

5 charts to watch
4:52 p.m. Jan. 15, 2014
- The Trading Deck

Apple closes lower; B. of A. rises on analyst call
5:15 p.m. Jan. 2, 2014
- Wallace Witkowski

Apple gains on China Mobile deal; homebuilders rally
4:33 p.m. Dec. 23, 2013
- Wallace Witkowski

Suspension is lifted for Ariad's leukemia drug
7:33 a.m. Dec. 23, 2013
- MarketWatch.com

J.C. Penney and more of the year's most profitable shorts

4:23 p.m. Dec. 9, 2013
- blogs.marketwatch.com

Hewlett-Packard, a cyclical green light and why silver is in trouble

9:50 a.m. Nov. 26, 2013
- Shawn Langlois

Ariad takes another pounding after leukemia treatment is pulled

1:14 p.m. Oct. 31, 2013
- Russ Britt

H-P has best day in four months on upbeat outlook
4:34 p.m. Oct. 9, 2013
- Sue Chang

Ariad plummets 70% after drug test patients have serious clotting issues

11:38 a.m. Oct. 9, 2013
- Russ Britt

FDA places partial hold on Ariad's Iclusig trials
8:16 a.m. Oct. 9, 2013
- MarketWatch.com

Dan Loeb makes bet on Disney
8:06 p.m. Aug. 14, 2013
- David Benoit

Onyx share surge lifts several boats in biotech harbor, including ETFs

11:33 a.m. July 1, 2013
- Russ Britt

SAC Capital Advisors likes this pharma stock
4:24 p.m. April 18, 2013
- Insider Monkey

Ariad Pharma up 6% to $20.09
11:35 a.m. Dec. 17, 2012
- Steve Gelsi

FDA OKs Iclusig to treat rare types of leukemia
2:06 p.m. Dec. 14, 2012
- MarketWatch.com

Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog

5:55 p.m. Sept. 23, 2014
- Zacks.com

Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit

12:05 p.m. Sept. 19, 2014
- TheStreet.com

InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG

9:58 a.m. Sept. 12, 2014
- Seeking Alpha

Biggest Movers in Healthcare Stocks Now – ISIS ARIA ACAD ALNY

8:00 a.m. Sept. 12, 2014
- InvestorPlace.com

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte

8:55 a.m. Sept. 5, 2014
- TheStreet.com

Biggest Movers in Healthcare Stocks Now – CLDX ARIA CNC ZMH

7:45 a.m. Sept. 4, 2014
- InvestorPlace.com

'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around

6:00 a.m. Sept. 4, 2014
- TheStreet.com

Cramer's Lightning Round - Yahoo Is A Good Steward Of Capital (9/3/14)

5:40 a.m. Sept. 4, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: These Are 3 Stocks Cramer Trusts

8:17 p.m. Sept. 3, 2014
- TheStreet.com

Biggest Movers in Healthcare Stocks Now – CYH ARIA THC LUX

8:15 a.m. Aug. 29, 2014
- InvestorPlace.com

Biotechs With Insider Buying

2:16 p.m. Aug. 22, 2014
- Seeking Alpha

Hottest Healthcare Stocks Now – ARIA CELG LCI RDY

9:15 a.m. Aug. 20, 2014
- InvestorPlace.com

InsiderInsights.com Daily Round Up: 8/19/14

3:36 a.m. Aug. 20, 2014
- Seeking Alpha

Hottest Healthcare Stocks Now – PTCT LGND WX BIIB

1:45 p.m. Aug. 15, 2014
- InvestorPlace.com

ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog

12:21 p.m. Aug. 11, 2014
- Zacks.com

Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript

5:30 p.m. Aug. 6, 2014
- Seeking Alpha

Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today

1:07 p.m. Aug. 6, 2014
- TheStreet.com

Ariad updates guidance after Q2 results

8:51 a.m. Aug. 6, 2014
- Seeking Alpha

ARIAD Pharmaceuticals (ARIA) Q2 2014 Results - Earnings Call Webcast

8:25 a.m. Aug. 6, 2014
- Seeking Alpha

Notable earnings before Wednesday’s open

5:30 p.m. Aug. 5, 2014
- Seeking Alpha

INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE
12:41 p.m. Sept. 16, 2014
- GlobeNewswire

Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen
8:55 a.m. Sept. 4, 2014
- PR Newswire - PRF

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
1:19 p.m. Aug. 19, 2014
- PR Newswire - PRF

ARIAD Reports Second Quarter 2014 Financial Results and Development
Progress
11:34 p.m. Aug. 6, 2014
- BusinessWire - BZX

ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel
7:36 a.m. Aug. 5, 2014
- BusinessWire - BZX

Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma
9:00 a.m. Aug. 1, 2014
- PR Newswire - PRF

ARIAD to Webcast Conference Call on Second Quarter 2014 Financial
Results
7:35 a.m. July 16, 2014
- BusinessWire - BZX

ARIAD Announces Continuation of Iclusig Review under the Article 20
Procedure in Europe
7:35 a.m. July 14, 2014
- BusinessWire - BZX

Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics
5:00 a.m. June 27, 2014
- PR Newswire - PRF

Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics
7:30 a.m. June 26, 2014
- PR Newswire - PRF

ARIAD Announces Three Key Appointments to Its Global Management Team
7:35 a.m. June 23, 2014
- BusinessWire - BZX

ARIAD Announces Pricing of $200 Million Offering of 3.625%
Convertible Senior Notes Due 2019
9:15 a.m. June 12, 2014
- BusinessWire - BZX

ARIAD Announces Proposed $175 Million Offering of Convertible Senior
Notes Due 2019
4:01 p.m. June 11, 2014
- BusinessWire - BZX

ARIAD Announces Webcast of Its Annual Shareholders Meeting
7:35 a.m. June 11, 2014
- BusinessWire - BZX

Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors
6:00 a.m. June 4, 2014
- PR Newswire - PRF

ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in
Patients with Gastrointestinal Stromal Tumors
9:01 a.m. June 1, 2014
- BusinessWire - BZX

ARIAD Presents Updated Phase 1/2 Data on AP26113
in Patients with ALK+ Non-Small Cell Lung Cancer
2:16 p.m. May 31, 2014
- BusinessWire - BZX

Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron
7:10 a.m. May 30, 2014
- PR Newswire - PRF

ARIAD to Present at Upcoming Investor Conferences
7:36 a.m. May 28, 2014
- BusinessWire - BZX

Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology
7:40 a.m. May 20, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WellBe Taps New Tech Chief to Elevate Home Care

In a move that's got the healthcare world buzzing, WellBe Senior Medical just brought in a heavyweight to steer its digital ship. They've appointed Jeffrey Brown as their new Chief Digital & Information Officer. What's shaking? Brown's stepping into the ring to tackle the age-old healthcare dilemma: making tech work smarter, not harder, especially at home. From High-Tech...

Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Aberdeen's Reverse Split: What Investors Need to Know

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Malteurop's Big Bet in China: A Malt Monopoly Move

Malteurop’s Ambitious Leap into China Folks, it looks like Malteurop, the malting arm of the French VIVESCIA Group, is digging its French roots deep into Chinese soil with a move that screams strategy. They’ve just scooped up the Chunlei Malting Co. plant in Jiangsu province, which cranks out enough malt to sling two billion liters of beer annually. Yeah, that's quite...

Molly Carlson Dives Into History on Icebergs

Turning Icebergs Into Diving Platforms: Molly Carlson's Bold Leap You ever hear about someone diving off an iceberg? I hadn't either until Molly Carlson decided to take the plunge—literally. Bringing guts to an icy landscape wasn't part of most people's adventure checklist, but for her, it was a shakeup of epic proportions. On June 11, 2026, out at Twillingate,...

Pre-Summer HVAC Tips: Safeguarding Your Business' Comfort

It's Not Just Another Day in HVAC Land When it comes to keeping the sweat off your brow come summertime, the unsung hero isn’t your air-conditioned office chair; it's the commercial HVAC system churning away behind the scenes. If you thought the summer’s furnace blast was just a personal discomfort, think again. It’s a hardcore gauntlet for any HVAC setup. So when...

Solenis Appoints Brendy Lange to Lead Americas Growth

New Leadership at Solenis Change is brewing at Solenis, and it's set to ripple across the water treatment industry like a stone in a pond. Brendy Lange's appointment as Chief Business Officer, Americas, promises to shake things up in a firm as committed to innovation as Solenis. This seasoned executive, scooped from the ranks of Dow Chemical, steps in with a mandate to...

Concrete Admixtures Market: A Billion-Dollar Boom

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

BioLineRx Explores Synergy in Ovarian Cancer Treatment

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Disorderly Magic: New Lithium Batteries Breakthrough

Disorder in Structure: A Game-Changer? Lithium-ion batteries—yeah, the gizmos powering your fancy electric cars and gadgets—might have just hit their next big break, all thanks to a little chaos. Over in Chungcheong Province, South Korea, researchers at Hanbat National University are messing with the atomic structure of lithium-rich cathodes, and guess what? They're...